Christian Oberbeck
Analyst
Sure. A couple of thoughts on that, and that is definitely something we spend a lot of time thinking about. I think there's some I'm not going to say unique, but some particular aspects of Saratoga that aren't necessarily shared with the whole BDC universe, and that is our large SBIC portfolio and investments. And the leverage in those is not counted the same as baby bond leverage, for example, in terms of the regulatory leverage. And so I think where regulatory leverage, it's one thing, from a total leverage, it's something else. And the character of the debt, and we've talked about this many times in our quarterly calls, it's really -- leverage -- if you have short-term leverage that's asset based and you're up to the limits of what the asset base formulas are and something goes against you, you can get foreclosed on by your banks, you can have a big accident. And it may be something temporary in nature like when COVID hit and things like that, but if you have leverage like, for example, the SBIC debt leverage, which those are 10-year instruments, interest only with no covenants. And so a lot of things can happen in 10 years, but if your only requirement is to repay the interest, the nature of that debt in terms of being something that's dangerous, if you will, to your -- to the health of the overall company is very, very low. And so -- and then the baby bonds are also very similar in that they are long-term instruments, bullet maturities, interest only, no covenants. So we've got very little -- almost all our debt has no covenants to speak of. Interest -- basically have to cover our interest. The interest is very small relative to our liquidity, relative to our earnings, relative to everything else. And so our overall debt structure is incredibly safe relative to the amount that it is. And so that's the liability side. Then the assets...